Biosynex SA (EPA:ALBIO)

France flag France · Delayed Price · Currency is EUR
1.190
-0.024 (-1.98%)
Feb 21, 2025, 5:02 PM CET
-77.46%
Market Cap 22.31M
Revenue (ttm) 104.07M
Net Income (ttm) -38.48M
Shares Out 18.75M
EPS (ttm) -3.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,566
Average Volume 54,174
Open 1.208
Previous Close 1.214
Day's Range 1.182 - 1.210
52-Week Range 1.054 - 6.920
Beta -2.04
RSI 44.20
Earnings Date Apr 23, 2025

About Biosynex

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women’s health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers, oxymeters, and... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1993
Employees 569
Stock Exchange Euronext Paris
Ticker Symbol ALBIO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.